Nuveen Asset Management, LLC Akebia Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 380,535 shares of AKBA stock, worth $738,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares

380,535

Previous 380,535 -0.0%

Holding current value

$738,237

Previous $502,000 40.84%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.86 - $1.63 $327,260 - $620,272	380,535 New	380,535 $388,000
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $417,676 - $1.7 Million	-580,106 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $16,061 - $23,737	7,107 Added 1.24%	580,106 $1.33 Million
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $16,475 - $27,202	-7,011 Reduced 1.21%	572,999 $1.66 Million
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $179,045 - $265,721	63,267 Added 12.24%	580,010 $2.2 Million
Q1 2021 May 17, 2021	SELL	$2.92 - $5.06 $876 - $1,517	-300 Reduced 0.06%	516,743 $1.75 Million
Q4 2020 Feb 16, 2021	SELL	$2.22 - $3.78 $2.56 Million - $4.37 Million	-1,154,823 Reduced 69.07%	517,043 $5.17 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $13.08 $236,433 - $1.29 Million	98,926 Added 6.29%	1,671,866 $16.7 Million
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $580,850 - $1.18 Million	87,084 Added 5.86%	1,572,940 $21.4 Million
Q1 2020 May 14, 2020	SELL	$4.1 - $10.24 $989,850 - $2.47 Million	-241,427 Reduced 13.98%	1,485,856 $11.3 Million
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $43,535 - $92,719	13,777 Added 0.8%	1,727,283 $10.9 Million
Q3 2019 Nov 14, 2019	BUY	$3.55 - $5.4 $299,896 - $456,181	84,478 Added 5.19%	1,713,506 $6.72 Million
Q2 2019 Aug 15, 2019	BUY	$4.1 - $8.05 $6.68 Million - $13.1 Million	1,629,028 New	1,629,028 $7.89 Million

Others Institutions Holding AKBA

# of Institutions

127

Shares Held

62.8M

Call Options Held

50.6K

Put Options Held

203K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $357M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Akebia Therapeutics, Inc. Transaction History